MXPA02000801A - Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad. - Google Patents
Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.Info
- Publication number
- MXPA02000801A MXPA02000801A MXPA02000801A MXPA02000801A MXPA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A
- Authority
- MX
- Mexico
- Prior art keywords
- nesp55
- obesity
- polynucleotides
- bovine
- linked
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un polipeptido que se puede derivar de NESP55 humano, en donde el polipeptido se puede derivar o anticipar de la secuencia de aminoacido de NESP55 humano que sera derivable mediante la disociacion edoproteolitica de un polipeptido que tiene la secuencia de aminoacido (I) o (II) (NESP55 humano) o una variante de la misma, en donde la variante de polipeptido tiene una secuencia de aminoacido que tiene al menos 90% de identidad con la secuencia de aminoacido proporcionada sola. La NESP55 o fragmentos de la misma, pueden ser utiles en medicina para el tratamiento de la obesidad.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9917165.4A GB9917165D0 (en) | 1999-07-22 | 1999-07-22 | Polypeptides polynuclcotides and uses thereof |
| PCT/EP2000/006921 WO2001007617A1 (en) | 1999-07-22 | 2000-07-20 | Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02000801A true MXPA02000801A (es) | 2004-03-19 |
Family
ID=10857699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02000801A MXPA02000801A (es) | 1999-07-22 | 2000-07-20 | Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1200591A1 (es) |
| JP (1) | JP2003505084A (es) |
| AU (1) | AU5986000A (es) |
| CA (1) | CA2380942A1 (es) |
| GB (1) | GB9917165D0 (es) |
| MX (1) | MXPA02000801A (es) |
| WO (1) | WO2001007617A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003006688A2 (en) * | 2001-07-13 | 2003-01-23 | University Of Aarhus | Methods for diagnosis and treatment of diseases associated with altered expression of gnas |
| WO2003027321A2 (en) * | 2001-09-24 | 2003-04-03 | University Of Aarhus | Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin |
| US20110138888A1 (en) * | 2008-07-21 | 2011-06-16 | Amany Elshorbagy | Treatment of obesity |
| CA2845617A1 (en) * | 2011-08-18 | 2013-02-21 | Otago Innovation Limited | Cardiovascular therapeutics |
| US11205153B1 (en) | 2013-11-15 | 2021-12-21 | Grubhub Holdings, Inc. | System and method for determining time of delivery of order |
-
1999
- 1999-07-22 GB GBGB9917165.4A patent/GB9917165D0/en not_active Ceased
-
2000
- 2000-07-20 WO PCT/EP2000/006921 patent/WO2001007617A1/en not_active Application Discontinuation
- 2000-07-20 CA CA002380942A patent/CA2380942A1/en not_active Abandoned
- 2000-07-20 JP JP2001512886A patent/JP2003505084A/ja active Pending
- 2000-07-20 AU AU59860/00A patent/AU5986000A/en not_active Abandoned
- 2000-07-20 EP EP00945936A patent/EP1200591A1/en not_active Withdrawn
- 2000-07-20 MX MXPA02000801A patent/MXPA02000801A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9917165D0 (en) | 1999-09-22 |
| WO2001007617A1 (en) | 2001-02-01 |
| EP1200591A1 (en) | 2002-05-02 |
| AU5986000A (en) | 2001-02-13 |
| JP2003505084A (ja) | 2003-02-12 |
| CA2380942A1 (en) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001006988A3 (en) | Super-active porcine growth hormone releasing hormone analog | |
| PL340755A1 (en) | Polypeptide-10 similar to mammal cytokin | |
| DE69634726D1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
| DE60135393D1 (de) | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 | |
| EP0055945A3 (en) | Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin | |
| WO1999024058A3 (en) | Neuronal uses of bmp-11 | |
| GB9801408D0 (en) | Frozen food product | |
| MXPA02000801A (es) | Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad. | |
| EP0249477A3 (en) | Functional recombinant analog polypeptides devoid of hydrophobic amino acids | |
| WO2004005317A3 (en) | Thrombin peptide derivative dimers | |
| EP1132402A4 (en) | PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY | |
| DE60036555D1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
| PL338649A1 (en) | Lactoferrin bonding neisseria protein | |
| AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
| WO1998022580A3 (en) | Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation | |
| WO2001098355A3 (en) | Cgi-69 compositions and methods of use | |
| ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| ATE123056T1 (de) | Ancrod-proteine, ihre herstellung und verwendung. | |
| EP0723016A3 (en) | Leukocyte activation factor | |
| DE69623803D1 (de) | Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer | |
| EP0287997A3 (en) | Des-19-leucine, 20-glutamine, 21-threonine-calcitonin | |
| DE60036676D1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine | |
| BR0012740A (pt) | Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego | |
| EP0290029A3 (en) | (19-alanine) calcitonin | |
| WO2000062805A8 (en) | A method of reversing thymic atrophy |